- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 17, 2025 | 312.5M sh |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $11.66B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $11.41B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.49B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.13B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.32B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.41B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $32.4B |
| Total Assets restated | Q1 2025 · Mar 31, 2024 | $31.38B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 315.69M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid restated | Q1 2025 · Mar 31, 2024 | $168M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $515M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $811M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $92M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $140M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.44 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.44 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $414M |
| Net Income | Q1 2025 · Mar 31, 2024 | $453.79M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $733M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $2.28B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $3.86B |